San Diego, CA, United States of America

Bryan R Meade

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations of Bryan R Meade

Introduction

Bryan R Meade is a notable inventor based in San Diego, California. He has made significant contributions to the field of immunology through his innovative patents. With a total of five patents to his name, Meade's work focuses on immunomodulating polynucleotides and their applications in pharmaceutical compositions.

Latest Patents

Among his latest patents, Meade has developed immunomodulating polynucleotides that may contain 5-modified uridine and 5-modified cytidine. These polynucleotides range from six to sixteen nucleotides in length and may include one or more abasic spacers and/or internucleoside phosphotriesters. Additionally, he has disclosed conjugates that contain a targeting moiety along with one or more immunomodulating polynucleotides. His work also includes compositions featuring these polynucleotides or conjugates, which may contain stereochemically enriched internucleoside phosphorothioates. Furthermore, he has introduced polynucleotide constructs that are linked to auxiliary moieties and methods for delivering these constructs to cells.

Career Highlights

Bryan R Meade has worked with prestigious institutions such as the University of California and Tollnine, Inc. His experience in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Meade has collaborated with notable colleagues, including Sukumar Sakamuri and Son Lam. These partnerships have likely enhanced the scope and impact of his research endeavors.

Conclusion

Bryan R Meade's innovative work in immunology and his contributions through multiple patents highlight his role as a significant inventor in the field. His research continues to pave the way for advancements in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…